Our Patients

Our patients’ journeys drive us to deliver therapies for unmet needs in eye health
Patients are central to our work here at Azura.
We understand the unmet needs that exist today in eye health and we are committed to discovering and delivering therapeutics that not only resolve the signs and symptoms of ocular surface diseases but address the underlying root causes of those conditions.

Expanded Access Program

Azura Ophthalmics is committed to providing safe and effective therapies to patients.  The indications being studied for our therapies do not qualify for Expanded Access (also known as Compassionate Use) as they are not considered immediately life-threatening, or serious diseases (e.g., sight-threatening).  Therefore, Azura Ophthalmics does not currently have an Expanded Access Program.

With information comes power!

Please consult the following resources for valuable insight and more, and be sure to follow us on social media, to keep up to date on our latest discovery news.
Twitter Linkedin-in

Resources

Clinical Trials

To learn more about, or consider participation in, a clinical study of one of our investigational therapies, please
Click Here
Scroll to Top